Saatvik Green Energy to Report Q2 FY27 Results on November 5
Key highlights
- Saatvik will report unaudited Q2 and H1 FY27 results on November 5, 2026.
- Q1 FY27 revenue declined 44.2% year-on-year to ₹511.01 crore.
- Q1 FY27 net profit was about ₹5.4 crore, down more than 95% year-on-year.
- Saatvik reported a confirmed order book of 6.35 GW against operational module capacity of 4.8 GW.
powered by IRIS

Saatvik Green Energy Limited is scheduled to report its Q2 FY27 results on November 5, 2026, following a Q1 FY27 revenue decline of 44.2% year-on-year to ₹511.01 crore and a net profit decline of more than 95% to about ₹5.4 crore.
Know Saatvik Green Energy inside out
Results, valuation, peers and who's buying, in one view.
When will Saatvik Green Energy report Q2 FY27 results?
Saatvik will announce unaudited financial results for the quarter and half-year ended September 30, 2026, on November 5, 2026. The company had informed exchanges that its board would meet to approve the Q2 and H1 FY27 financial statements. The trading window is set to reopen 48 hours after the results are declared.
Saatvik has also scheduled an investor call at 6:00 PM IST on November 5 to discuss the Q2 and H1 FY27 performance. Senior management, including the Chairman, Chief Executive Officer and Interim Chief Financial Officer, are expected to participate. Shareholders and investors will be able to hear management's discussion on the reported quarter and the company's outlook.
The release is important because it follows a sharp year-on-year decline in the June 2026 quarter. Q1 FY27 revenue stood at ₹511.01 crore, compared with ₹915.73 crore in Q1 FY26, while net profit fell to roughly ₹5.4 crore from ₹116.60 crore in the preceding-year quarter.
What happened to Saatvik's Q1 FY27 earnings?
Saatvik's Q1 FY27 performance reflected lower volumes and weaker profitability compared with the year-ago period. Revenue declined 44.2% year-on-year to ₹511.01 crore, and EBITDA fell 80.5% to ₹33.83 crore from ₹173.68 crore. The EBITDA margin narrowed to 6.6% from about 19% in Q1 FY26.
Net profit for the June 2026 quarter was about ₹5.4 crore, representing a decline of more than 95% from the comparable quarter a year earlier. Quarterly operating profit was ₹33.83 crore, while operating profit margin was 6.62%, compared with 19.33% in June 2025. Interest expense increased to ₹21.74 crore from ₹19.04 crore over the same comparison.
The company has said that cell production is expected to begin contributing to revenue in H2 FY27. Management expects the facility to reach full ramp-up within three months, with utilisation of around 80% targeted during January to March 2027. It has indicated that Q2 volumes may improve, although margins could remain under pressure before the new capacity contributes more meaningfully.
Which figures should investors track in the Q2 FY27 release?
Investors will likely focus on revenue recovery, operating margin, profitability and the pace of cell-production ramp-up in the Q2 FY27 announcement. These measures will show how the company is progressing after the low-volume June quarter and whether its stated H2 FY27 capacity plan is taking effect.
The order book will remain a key operational indicator. Saatvik reported a confirmed backlog of about 6.35 GW, equal to around 132% of its operational module capacity of 4.8 GW. The company has also received a Solar Energy Corporation of India order for solar photovoltaic modules worth ₹1,041.63 crore, with delivery required by December 2027.
Got a follow-up? Ask IRIS
How does Q2 compare with Saatvik's earlier growth?
Saatvik's forthcoming update follows a period of strong growth in H1 FY26. Revenue from operations during that half-year rose 133% year-on-year to ₹1,683.8 crore from ₹721.3 crore. Profit after tax increased more than 146% to ₹202.1 crore from ₹82.3 crore, according to the company's previous disclosure.
The contrast between that performance and Q1 FY27 makes the September-quarter update more relevant for investors assessing operational consistency. The company has cited reduced volumes in the June quarter, while also maintaining that its backlog remains substantial. The Q2 figures can provide an updated view of volumes, profitability and the status of new cell capacity.
On a trailing 12-month basis, Saatvik reported revenue of ₹4,144 crore, cost of revenue of ₹3,298 crore and gross profit of ₹846 crore. Other expenses were ₹600 crore, resulting in earnings of ₹246 crore. Revenue had grown 47% over the previous year, while earnings per share had declined 19%.
What could the Q2 results mean for investors and operations?
The Q2 release will provide a reported measure of whether Saatvik is moving towards its FY27 guidance of sales of 3.5-4 GW and revenue of around ₹6,000 crore. Management has also guided for an operating margin of around 12% and a profit margin of 6-7% for FY27, making quarterly margin movement a central point of review.
For the solar manufacturing industry, the results will also reflect the execution challenge of scaling production while managing volumes, costs and capacity utilisation. Saatvik's reported order backlog and the SECI module order provide visibility on contracted demand, but the financial contribution will depend on the timing of deliveries and production execution.
The investor call offers a formal opportunity for management to address the September-quarter results and its outlook. Investors will be looking for company commentary on the cell-production ramp-up, expected utilisation, order execution and the factors behind the lower margins reported in Q1 FY27.
Conclusion
Saatvik is due to release Q2 FY27 results on November 5 after a June quarter marked by a 44.2% revenue decline and a significant contraction in profit and EBITDA margin. The update matters because the company is seeking to convert a 6.35 GW confirmed order book into higher volumes while expanding into cell production.
The immediate focus will be on the reported Q2 revenue, operating margin and profit figures, followed by management's comments during the 6:00 PM IST investor call. Investors will also watch for progress toward the company's target of around 80% cell-capacity utilisation during January to March 2027 and its FY27 sales and margin guidance.


